Viewing StudyNCT00189670



Ignite Creation Date: 2024-05-05 @ 11:57 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00189670
Status: COMPLETED
Last Update Posted: 2005-09-19
First Post: 2005-09-12

Brief Title: Randomized Phase II Trial of Dose Dense Docetaxel in N Breast Cancer
Sponsor: Association Européenne de Recherche en Oncologie
Organization: Association Européenne de Recherche en Oncologie

Organization Data

Organization: Association Européenne de Recherche en Oncologie
Class: OTHER
Study ID: AERO-B03
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Association Européenne de Recherche en Oncologie
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Amgen INDUSTRY
Aventis Pharmaceuticals INDUSTRY